This recall is not due to any particular product complaint or determination of out of ROSUVASTATIN T. P . . ROSUVASTATIN T.
The last Recall Enforcement Report for Rosuvastatin with NDC was initiated on as a Class II recall due to cgmp deviations: recalling drug products following an fda inspection.
by A de Bartolomeis 2024 Cited by 2023 Ligand-Receptor Interaction Framework Relevant for Aripiprazole Mechanism of Action. Nowadays, the basic definition of agonist/antagonist
Pharmaceutical Products Recalled from the Lebanese Market according to Minister's Decision No. 1141/1 Date ; C10AA07, APO-ROSUVASTATIN, G Rosuvastatin
Mandated? Voluntary: Firm initiated. Recall Number, D- . Event ID, . Brand, ROSUVASTATIN. Generic Name, ROSUVASTATIN. Manufacturer, ROSUVASTATIN.
The last Recall Enforcement Report for Rosuvastatin with NDC was initiated on as a Class II recall and it is currently terminated.
Recall Studies Matter? Long-Term Atorvastatin was prescribed at least once to 70.4%, rosuvastatin to 63.0%, and medication combinations (rosuvastatin
The last Recall Enforcement Report for Rosuvastatin with NDC was initiated on as a Class II recall due to cgmp deviations: recalling drug products following an fda inspection. The latest recall number for this product is D- and the recall is currently terminated as of .
2024 regarding medical devices recall and Field Safety Corrective Actions rosuvastatin) and pharmaceutical products that contains (amlodipine/ rosuvastatin).
Comments